Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Metal Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113307790B reveals a metal-free oxidative cyclization route for 1,2,4-triazoles. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with this scalable method.
Patent CN107459533B discloses stable phosphine ligands enabling low-loading palladium catalysis. Discover cost-effective solutions for pharmaceutical intermediate manufacturing.
Patent CN113004236A details a green POMs-catalyzed route for phthalide derivatives, offering cost-effective and scalable production for pharmaceutical intermediates.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of bioactive heterocycles.
Novel metal-free oxidative cyclization method for high-purity triazole intermediates. Reduces cost and simplifies supply chain for pharma manufacturing.
Patent CN113307790B reveals a metal-free oxidative cyclization route for bioactive triazoles, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Novel Rh-catalyzed aminocarbonylation using dimethyl carbonate offers a green, high-yield route for acetamide production, ensuring cost-effective supply chain solutions.
Patent CN111468191A details a safe, scalable phosphorus ylide route for Grubbs catalysts, offering cost reduction and supply chain stability for fine chemical manufacturing.
Patent CN107382741B details a high-yield B(C6F5)3 catalyzed hydroamination. Offers cost-effective, scalable routes for pharmaceutical intermediates with minimal impurities.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of bioactive heterocycles.
Patent CN104402934B reveals low-loading ruthenium catalysts for green quinoline synthesis, offering cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN106243033A enables low-temperature aryl nitrile production. Achieve cost reduction in pharmaceutical intermediate manufacturing with high-purity outputs.
Patent CN111518021B reveals a novel iodide-catalyzed oxidative cyclization using styrene and DMF, offering a cost-effective, metal-free route for high-purity pharmaceutical intermediates.
Novel metal-free oxidative cyclization method for 1,2,4-triazoles. High yields, scalable process for API intermediates avoiding heavy metals.
Patent CN113307778A reveals a novel Mo/Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering mild conditions and high efficiency for API manufacturing.
Patent CN113307790B reveals a metal-free route to 3-quinolyl-5-trifluoromethyl-1,2,4-triazoles, offering cost reduction in API manufacturing and scalable production.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of key heterocyclic building blocks.
Novel metal-free oxidative cyclization method for high-purity triazole intermediates. Reduces steps from five to one, ensuring cost-effective supply chain solutions.
Patent CN106946875A details green synthesis for high-purity imidazole intermediates. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Patent CN113307790B reveals a metal-free oxidative cyclization route for high-purity triazole intermediates, offering significant cost reduction in pharmaceutical manufacturing.